Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Phosphorus or phosphorus compound
Patent
1996-05-13
1998-06-16
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Phosphorus or phosphorus compound
424610, 424663, 424673, A61K 3343, A61K 3314
Patent
active
057666393
ABSTRACT:
The invention provides a composition and method for reducing molecular defects in metastable tissue systems. Molecular defects represent spaces or vacancies in the structural order of the metastable system. The effect of molecular defects can be minimized such that the pre-defect order is preserved through the use of structure makers. These structure makers will then occupy the space or vacancy of the molecular defect, preserving the pre-defect order of the system. Lithium ions are a preferred structure maker.
REFERENCES:
patent: 4490351 (1984-12-01), Clark, Jr.
patent: 5096918 (1992-03-01), Mallion
Publication entitled "Overview of the Current Attempts Toward the Medical Treatment of Cataract", Author-Peter F. Kador; Ophthalmology, vol. 90, No. 4, Apr. 1983, pp. 352-364.
N.E. Barklage and J.W. Jefferson, Psychosomatics, The Journal of the Academy of Psychosomatic Medicine 28:No. 5 (1987).
J.J. Corbett et al., Neurology 39:481-487 (1989).
K. DasGupta and J.W. Jefferson, General Hospital Psychiatry 123-97 (1990).
F.T. Franunfelder et al., J Toxicol-Cut & Ocular Toxicol 11(2):97-169 (1992).
J.W. Jefferson, in Current Psychiatric Therapy, D.L. Dunner (Ed.), W.B. Saunders Company, Philadephia PA (1993), pp. 246-254.
J.W. Jefferson and J.H. Greist, in Comprehensive Textbook of Psychiatry 5th Ed. vol. 2, H.I. Kaplan and B.J. Sadock (Eds.), Williams & Wilkins, Baltimore, Maryland (1989), pp. 1655-1662.
J.W. Jefferson and J.H. Greist, Hospital Therapy 12:74-99 (1987).
F.N. Johnson, in Depression & Mania: Modern Lithium Therapy, F.N. Johnson (Ed.), IRL Press, Oxford, Washington, D.C. (1987), pp. 245-246.
T. Kasamatsu et al., Brain Research 558:157-162 (1991).
P.L. Kaufman et al., Acta Ophthalmologica 63:327-332 (1985).
M. Schou, in Depression & Mania: Modern Lithium Therapy, F.N. Johnson (Ed.), IRL Press, Oxford, Washington, D.C. (1987), pp. 44-50.
M. Schou, J Psychiatr Res 22:287-296 (1988).
H.C. Stancer and N. Forbath, Arch Intern Med 149:1042-1045 (1989).
U.S. Dept. of Health and Human Services Publication No. (ADM) 91-1868, Bipolar Disorder) (1991).
"Current and Potential uses of Lithium", Academic Highlights of a symposium sponsored by the FMC Corporation, Lithium Division, at the Annual Meeting of the American Psychiatric Association in San Francisco, California (May 7, 1989).
"Lithium & Manic Depression: A Guide", published by the Lithium Information Center and the Dean Foundation for Health, Research and Education, Madison, Wisconsin (1992).
J.J. Harding et al., Acta Ophthalmologica 67:518-524 (1989).
J.J. Harding and R. Van Heyningen, British Journal of Ophthalmology 72:809-814 (1988).
J.M Seddon et al., Arch Ophthalmol 109:252-255 (1991).
B.E.K. Klein et al., Diabetes Care 10:495-499 (1987).
N.E. Isaac et al., Arch Ophthalmol 109:256-260 (1991).
W.K. Clair et al., British Journal of Ophthalmology 73:173-176 (1989).
R. Peto et al., British Medical Journal 296:313-316 (1988).
H. Cheng, British Journal of Ophthalmology 76:257 (1992).
Handbook of Aqueous Electrolyte Solutions, by A.L. Horvath, Ellis Horwood Limited, Chichester (1985), pp. 9-33.
Kandel Gillray L.
Schroeder John
Fay Zohreh
Rensselaer Polytechnic Institute
LandOfFree
Composition and method for reducing molecular defects in non-ren does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for reducing molecular defects in non-ren, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for reducing molecular defects in non-ren will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1722243